NCT00675636

Brief Summary

RATIONALE: Gathering medical and family history information from patients and family members may help doctors better understand hereditary colorectal cancer and hereditary polyposis syndrome and identify patients at high risk of developing hereditary colorectal cancer. PURPOSE: This research study is collecting information from patients and family members with hereditary colorectal cancer or polyposis syndrome or who are at high risk of developing hereditary colorectal cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
730

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 8, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 9, 2008

Completed
9.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

August 2, 2017

Status Verified

August 1, 2017

Enrollment Period

10.4 years

First QC Date

May 8, 2008

Last Update Submit

August 1, 2017

Conditions

Keywords

colon cancerhereditary non-polyposis colon cancerrectal cancerfamilial adenomatous polyposis

Outcome Measures

Primary Outcomes (1)

  • Identification of patients at high risk of developing hereditary colorectal cancer

    Database will continue indefinitely with IRB approval and investigator support

    continuous data collection

Secondary Outcomes (1)

  • Establishment of a tissue and data repository

    continuous data collection

Interventions

database, no intervention

database, no intervention

Eligibility Criteria

AgeUp to 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Anyone with known or suspected hereditary colorectal cancer syndrome, early age o onset of colorectal cancer (see below).

DISEASE CHARACTERISTICS: * Meets any of the following criteria: * Patients and family members with a known hereditary colorectal cancer or polyposis syndrome * Patients who meet Amsterdam I, II, or Bethesda criteria * Patients with a family history suggestive of a hereditary colorectal or polyposis syndrome * Patients diagnosed with colorectal cancer at \< 50 years old * Patients are identified through surgical, oncological, gynecological, and gastrointestinal programs, as well as outside referrals, self referral, and the Vanderbilit Tumor Registry PATIENT CHARACTERISTICS: * See Disease Characteristics PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (3)

Vanderbilt-Ingram Cancer Center - Cool Springs

Nashville, Tennessee, 37064, United States

Location

Vanderbilt-Ingram Cancer Center at Franklin

Nashville, Tennessee, 37064, United States

Location

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, 37232-6838, United States

Location

MeSH Terms

Conditions

Colorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisPrecancerous ConditionsColonic NeoplasmsRectal NeoplasmsAdenomatous Polyposis Coli

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDNA Repair-Deficiency DisordersMetabolic DiseasesNutritional and Metabolic DiseasesAdenomatous PolypsAdenomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeIntestinal Polyposis

Study Officials

  • Paul Wise, MD

    Vanderbilt-Ingram Cancer Center

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 8, 2008

First Posted

May 9, 2008

Study Start

January 1, 2007

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

August 2, 2017

Record last verified: 2017-08

Locations